Advances in transformable drug delivery systems

被引:63
作者
Hu, Quanyin [1 ,2 ,3 ,4 ]
Chen, Qian [1 ,2 ,3 ,4 ]
Gu, Zhen [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, Raleigh, NC 27695 USA
[2] North Carolina State Univ, Raleigh, NC 27695 USA
[3] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacoengn & Mol Pharmaceut, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Eshelman Sch Pharm, Ctr Nanotechnol Drug Delivery, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA
关键词
Drug delivery; Stimuli-responsive; Cancer therapy; Transformable formulation; STIMULI-RESPONSIVE NANOCARRIERS; TUMOR MICROENVIRONMENT; CANCER-THERAPY; GOLD NANOPARTICLES; INDUCED AGGREGATION; BIOLOGICAL-SYSTEMS; THERANOSTIC AGENTS; CONTROLLED-RELEASE; TARGETED DELIVERY; RATIONAL DESIGN;
D O I
10.1016/j.biomaterials.2018.03.056
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
These years, transformable drug delivery systems (DDSs), which hold the capability of changing formulation morphology and subsequent functionality at the desired disease site, have shown great promise in control of spatio-temporal drug delivery/release manner and enhanced treatment efficacy. Equipped with controllability and design flexibility, the transformable DDSs are being increasingly pursued for the development of precision drug delivery platforms for biomedical applications. In this review, we describe the recently developed intracelluarly and extracellularly transformable DDSs, especially associated with assembly or disassociation of the original formulation units, for achieving various functionalities, including prolonged retention time, inhibited endocytosis and enhanced cytotoxicity. Furthermore, the different stimuli, such as pH, enzyme, light, temperature, redox and mechanical force that trigger the transformation process are also introduced. The future outlook and challenges are discussed in the end. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:546 / 558
页数:13
相关论文
共 124 条
[1]   In vivo covalent cross-linking of photon-converted rare-earth nanostructures for tumour localization and theranostics [J].
Ai, Xiangzhao ;
Ho, Chris Jun Hui ;
Aw, Junxin ;
Attia, Amalina Binte Ebrahim ;
Mu, Jing ;
Wang, Yu ;
Wang, Xiaoyong ;
Wang, Yong ;
Liu, Xiaogang ;
Chen, Huabing ;
Gao, Mingyuan ;
Chen, Xiaoyuan ;
Yeow, Edwin K. L. ;
Liu, Gang ;
Olivo, Malini ;
Xing, Bengang .
NATURE COMMUNICATIONS, 2016, 7
[2]  
Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]
[3]   The tumour microenvironment as a target for chemoprevention [J].
Albini, Adriana ;
Sporn, Michael B. .
NATURE REVIEWS CANCER, 2007, 7 (02) :139-147
[4]   Probe for the measurement of cell surface pH in vivo and ex vivo [J].
Anderson, Michael ;
Moshnikova, Anna ;
Engelman, Donald M. ;
Reshetnyak, Yana K. ;
Andreev, Oleg A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (29) :8177-8181
[5]   Glucose metabolism in cancer cells [J].
Annibaldi, Alessandro ;
Widmann, Christian .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2010, 13 (04) :466-470
[6]   Targeting death and decoy receptors of the tumour-necrosis factor superfamily [J].
Ashkenazi, A .
NATURE REVIEWS CANCER, 2002, 2 (06) :420-430
[7]   Exocytosis of peptide functionalized gold nanoparticles in endothelial cells [J].
Bartczak, Dorota ;
Nitti, Simone ;
Millar, Timothy M. ;
Kanaras, Antonios G. .
NANOSCALE, 2012, 4 (15) :4470-4472
[8]   Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells [J].
Bassi, DE ;
De Cicco, RL ;
Mahloogi, H ;
Zucker, S ;
Thomas, G ;
Klein-Szanto, AJP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10326-10331
[9]   Stimuli-Responsive Nanomaterials for Biomedical Applications [J].
Blum, Angela P. ;
Kammeyer, Jacquelin K. ;
Rush, Anthony M. ;
Callmann, Cassandra E. ;
Hahn, Michael E. ;
Gianneschi, Nathan C. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (06) :2140-2154
[10]   The role of platelet activation in tumor metastasis [J].
Borsig, Lubor .
EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (08) :1247-1255